Medicinova Inc
MNOV- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001226616
In the last 90 days, Medicinova Inc insiders filed 0 open-market purchases and 1 sale; 29 institutions reported holding it in 13F filings for Q2 2026, worth $6.84M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Medicinova Inc changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 30 | 34 | +4 |
| Shares | 5.01M | 4.83M | −171.9K (−3.4%) |
| Value | $10.5M | $7.25M | −$3.21M (−30.7%) |
New holders (6)
Institutions that held Medicinova Inc at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank Julius Baer & Co. Ltd, Zurich | 19,000 | $28.5K | 0.00% |
| Jane Street Group, LLC | 14,345 | $21.5K | 0.00% |
| Goldman Sachs Group Inc | 10,944 | $16.4K | 0.00% |
| Hantz Financial Services, Inc. | 1,800 | $3.00K | 0.00% |
| Royal Bank of Canada | 849 | $1.00K | 0.00% |
| Simplex Trading, LLC | 218 | $0 | 0.00% |
Sold out (2)
Institutions that held Medicinova Inc at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| HRT Financial LP | 124,884 | $261.0K |
| Capricorn Fund Managers Ltd | 30,459 | $63.7K |